D020533Chemicals & DrugsPhysiologyD27.505.696.377.077.099D27.505.696.377.450.100D27.505.954.248.025240.996704Angiogenesis Inhibitorscmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson3Assistant Professor0.4589550.201242research area of0.2335350.1273345subject area forPediatricsResearchClinicalChildren's Mercy Kansas CityMDChristopherNitkinChristopher R. Nitkin0.000000000000000.00000000000000182Nitkin, Christopher0000-0001-5718-4523Physician33667496Tan H, Blasco P, Lewis T, Ostmo S, Chiang MF, Campbell JPSurvey of ophthalmologyTan H, Blasco P, Lewis T, Ostmo S, Chiang MF, Campbell JP. Neurodevelopmental outcomes in preterm infants with retinopathy of prematurity. Surv Ophthalmol. 2021 Sep-Oct; 66(5):877-891.Surv Ophthalmol2021-03-02T00:00:002021Neurodevelopmental outcomes in preterm infants with retinopathy of prematurity.Hematology/Oncology/BMTPhDVivekanandYadavVivekanand Yadav0.000000000000000.00000000000000215Yadav, VivekanandDoctoral Research Faculty29660022Yadav VN, Altshuler D, Kadiyala P, Zamler D, Comba A, Appelman H, Dunn P, Koschmann C, Castro MG, L?wenstein PRNeuro-oncologyYadav VN, Altshuler D, Kadiyala P, Zamler D, Comba A, Appelman H, Dunn P, Koschmann C, Castro MG, L?wenstein PR. Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab. Neuro Oncol. 2018 09 03; 20(10):1356-1367.Neuro Oncol2018-09-03T00:00:002018Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab.25117977Baker GJ, Yadav VN, Motsch S, Koschmann C, Calinescu AA, Mineharu Y, Camelo-Piragua SI, Orringer D, Bannykh S, Nichols WS, deCarvalho AC, Mikkelsen T, Castro MG, Lowenstein PRNeoplasia (New York, N.Y.)Baker GJ, Yadav VN, Motsch S, Koschmann C, Calinescu AA, Mineharu Y, Camelo-Piragua SI, Orringer D, Bannykh S, Nichols WS, deCarvalho AC, Mikkelsen T, Castro MG, Lowenstein PR. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia. 2014 Jul; 16(7):543-61.Neoplasia2014-07-01T00:00:002014Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.36201183Nitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis TJAMA ophthalmologyNitkin CR, Bamat NA, Lagatta J, DeMauro SB, Lee HC, Patel RM, King B, Slaughter JL, Campbell JP, Richardson T, Lewis T. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity. JAMA Ophthalmol. 2022 11 01; 140(11):1085-1094.JAMA Ophthalmol2022-11-01T00:00:002022Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.36862400Nitkin CR, Richardson T, Lewis TJAMA ophthalmologyNitkin CR, Richardson T, Lewis T. Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply. JAMA Ophthalmol. 2023 04 01; 141(4):408-409.JAMA Ophthalmol2023-04-01T00:00:002023Is Anti-Vascular Growth Factor Therapy for Retinopathy of Prematurity Associated With Pulmonary Hypertension?-Reply.true1Doctoral Research FacultyDoctoral Research Facultytrue1PhysicianPhysician